Clinical trial
Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis…
NCT00431964 · CF Therapeutics Development Network Coordinating Center, Other · Completed
Key facts
| NCT number | NCT00431964 |
|---|---|
| Title | Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa |
| Official title | Multi-center, Multi-national, Randomized, Placebo-Controlled Trial of Azithromycin in Subjects With Cystic Fibrosis 6-18 Years Old, Culture Negative for Pseudomonas Aeruginosa |
| Lead sponsor | CF Therapeutics Development Network Coordinating Center, Other |
| Collaborators | Cystic Fibrosis Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cystic Fibrosis |
| Intervention type | Drug |
| Interventions | azithromycin 250 mg tablets, placebo tablets |
| Enrollment | 263 |
| Start date | Feb 1, 2007 |
| Primary completion | Jul 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Feb 6, 2007 |
| Last update posted | Aug 19, 2015 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: